AML management now hinges on molecularly defined subtypes, supported by numerous targeted approvals; expanding trial access ...

Earlier, systematic supportive and palliative integration, plus streamlined logistics and clearer counseling on novel-therapy AE profiles, could reduce household disruption during treatment and ...

As discussed at a recent IVBM event, Robert Kratzke, MD, outlines essential biomarkers, NGS panel selection, and next steps ...

National health spending is forecast to approach $9 trillion by 2034, increasing faster than GDP and consuming 20.6% of the ...